These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21046245)

  • 1. The effect of antisecretory therapy and study duration on ambulatory esophageal pH monitoring.
    Kushnir VM; Sayuk GS; Gyawali CP
    Dig Dis Sci; 2011 May; 56(5):1412-9. PubMed ID: 21046245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain.
    Kushnir VM; Sayuk GS; Gyawali CP
    Am J Gastroenterol; 2010 May; 105(5):1032-8. PubMed ID: 19920808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of wireless pH monitoring technologies: a summary of the proceedings from the esophageal diagnostic working group.
    Richter JE; Pandolfino JE; Vela MF; Kahrilas PJ; Lacy BE; Ganz R; Dengler W; Oelschlager BK; Peters J; DeVault KR; Fass R; Gyawali CP; Conklin J; DeMeester T;
    Dis Esophagus; 2013; 26(8):755-65. PubMed ID: 22882487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mean Nocturnal Baseline Impedance Correlates With Symptom Outcome When Acid Exposure Time Is Inconclusive on Esophageal Reflux Monitoring.
    Rengarajan A; Savarino E; Della Coletta M; Ghisa M; Patel A; Gyawali CP
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):589-595. PubMed ID: 31163276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring.
    Patel A; Sayuk GS; Gyawali CP
    Neurogastroenterol Motil; 2016 Sep; 28(9):1382-90. PubMed ID: 27061427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Impedance-pH Testing on Medications Reliably Identify Patients with GERD as Defined by Pathologic Esophageal Acid Exposure off Medications?
    Ward MA; Dunst CM; Glasgow ME; Teitelbaum EN; Abdelmoaty WF; Reavis KM; SwanstrÓ§m LL; DeMeester SR
    J Gastrointest Surg; 2019 Jul; 23(7):1301-1308. PubMed ID: 30859425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged Wireless pH Monitoring in Patients With Persistent Reflux Symptoms Despite Proton Pump Inhibitor Therapy.
    Hasak S; Yadlapati R; Altayar O; Sweis R; Tucker E; Knowles K; Fox M; Pandolfino J; Gyawali CP
    Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2912-2919. PubMed ID: 32007543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term wireless pH monitoring of the distal esophagus: prolonging the test beyond 48 hours is unnecessary and may be misleading.
    Capovilla G; Salvador R; Spadotto L; Voltarel G; Pesenti E; Perazzolo A; Nicoletti L; Merigliano S; Costantini M
    Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial.
    Yadlapati R; Masihi M; Gyawali CP; Carlson DA; Kahrilas PJ; Nix BD; Jain A; Triggs JR; Vaezi MF; Kia L; Kaizer A; Pandolfino JE
    Gastroenterology; 2021 Jan; 160(1):174-182.e1. PubMed ID: 32949568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough.
    Ribolsi M; Savarino E; De Bortoli N; Balestrieri P; Furnari M; Martinucci I; Casale M; Greco F; Salvinelli F; Savarino V; Marchi S; Cicala M
    Aliment Pharmacol Ther; 2014 Oct; 40(8):966-73. PubMed ID: 25109844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation.
    Patel A; Sayuk GS; Kushnir VM; Chan WW; Gyawali CP
    Neurogastroenterol Motil; 2016 Apr; 28(4):513-21. PubMed ID: 26686239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model to Select On-Therapy vs Off-Therapy Tests for Patients With Refractory Esophageal or Extraesophageal Symptoms.
    Patel DA; Sharda R; Choksi YA; Slaughter JC; Higginbotham T; Garrett CG; Francis DO; Ravi K; Hasak S; Katzka D; Gyawali CP; Vaezi MF
    Gastroenterology; 2018 Dec; 155(6):1729-1740.e1. PubMed ID: 30170117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid-based parameters on pH-impedance testing predict symptom improvement with medical management better than impedance parameters.
    Patel A; Sayuk GS; Gyawali CP
    Am J Gastroenterol; 2014 Jun; 109(6):836-44. PubMed ID: 24732868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 24 Versus 48-hour bravo pH monitoring.
    Chander B; Hanley-Williams N; Deng Y; Sheth A
    J Clin Gastroenterol; 2012 Mar; 46(3):197-200. PubMed ID: 21959323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease.
    Prakash C; Clouse RE
    Clin Gastroenterol Hepatol; 2005 Apr; 3(4):329-34. PubMed ID: 15822037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term therapeutic outcome of patients undergoing ambulatory pH monitoring for chronic unexplained cough.
    Hersh MJ; Sayuk GS; Gyawali CP
    J Clin Gastroenterol; 2010 Apr; 44(4):254-60. PubMed ID: 19826278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.